Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 4786 AL 4800

The role of nutrition on Parkinson's disease: a systematic review

Bianchi VE, Rizzi L, Somaa F.

Nutr Neurosci. 2023 Jul;26(7):605-628. doi: 10.1080/1028415X.2022.2073107. Epub 2022 Jun 22.

The Effect of Cannabidiol for Restless Legs Syndrome/Willis-Ekbom Disease in Parkinson's Disease Patients with REM Sleep Behavior Disorder: A Post Hoc Exploratory Analysis of Phase 2/3 Clinical Trial

de Almeida CMO, Brito MMC, Bosaipo NB, Pimentel AV, Sobreira-Neto MA, Tumas V, Zuardi AW, Crippa JAS, Hallak JEC, Eckeli AL.

Cannabis Cannabinoid Res. 2023 Apr;8(2):374-378. doi: 10.1089/can.2021.0158. Epub 2022 Jun 24.

Acute myocardial infarction in a patient with MELAS syndrome: a possible link?

Cosma J, Russo A, Schino S, Belli M, Mango R, Chiricolo G, Martuscelli E, Mariano EG.

Minerva Cardiol Angiol. 2023 Aug;71(4):374-380. doi: 10.23736/S2724-5683.22.06021-5. Epub 2022 Jun 29.

Magnetic Resonance Imaging Studies of Neurodegenerative Disease: From Methods to Translational Research

Huang P, Zhang M.

Neurosci Bull. 2023 Jan;39(1):99-112. doi: 10.1007/s12264-022-00905-x. Epub 2022 Jun 30.

What Do Randomized Controlled Trials Inform Us About Potential Disease-Modifying Strategies for Parkinson's Disease?

Ong WY, Leow DM, Herr DR, Yeo CJ.

Neuromolecular Med. 2023 Mar;25(1):1-13. doi: 10.1007/s12017-022-08718-x. Epub 2022 Jul 1.

Effects of Therapeutic Intervention on Spatiotemporal Gait Parameters in Adults With Neurologic Disorder: Systematic Review and Meta-analysis

Bishnoi A, Shankar M, Lee R, Hu Y, Hernandez ME.

Arch Phys Med Rehabil. 2023 Mar;104(3):451-474. doi: 10.1016/j.apmr.2022.06.003. Epub 2022 Jul 3.

Liquid-liquid Phase Separation of α-Synuclein: A New Mechanistic Insight for α-Synuclein Aggregation Associated with Parkinson's Disease Pathogenesis

Mukherjee S, Sakunthala A, Gadhe L, Poudyal M, Sawner AS, Kadu P, Maji SK.

J Mol Biol. 2023 Jan 15;435(1):167713. doi: 10.1016/j.jmb.2022.167713. Epub 2022 Jul 3.

Functional and Pathological Effects of α-Synuclein on Synaptic SNARE Complexes

Gao V, Briano JA, Komer LE, Burré J.

J Mol Biol. 2023 Jan 15;435(1):167714. doi: 10.1016/j.jmb.2022.167714. Epub 2022 Jul 3.

Current opinions on mitophagy in fungi

Shen ZF, Li L, Zhu XM, Liu XH, Klionsky DJ, Lin FC.

Autophagy. 2023 Mar;19(3):747-757. doi: 10.1080/15548627.2022.2098452. Epub 2022 Jul 11.

Prion strains: shining new light on old concepts

Block AJ, Bartz JC.

Cell Tissue Res. 2023 Apr;392(1):113-133. doi: 10.1007/s00441-022-03665-2. Epub 2022 Jul 7.

Aerobic capacity in persons with Parkinson's disease: a systematic review

Thrue C, Hvid LG, Gamborg M, Dawes H, Dalgas U, Langeskov-Christensen M.

Disabil Rehabil. 2023 Jul;45(15):2409-2421. doi: 10.1080/09638288.2022.2094480. Epub 2022 Jul 10.

Artificial intelligence and machine-learning approaches in structure and ligand-based discovery of drugs affecting central nervous system

Gautam V, Gaurav A, Masand N, Lee VS, Patil VM.

Mol Divers. 2023 Apr;27(2):959-985. doi: 10.1007/s11030-022-10489-3. Epub 2022 Jul 11.

Molecular genetics of Parkinson's disease: Contributions and global trends

Funayama M, Nishioka K, Li Y, Hattori N.

J Hum Genet. 2023 Mar;68(3):125-130. doi: 10.1038/s10038-022-01058-5. Epub 2022 Jul 11.

Polysomnographic and Clinical Parameters before and after Zonisamide Therapy for Parkinson's Disease

Miyaue N, Yabe H.

Intern Med. 2023 Feb 15;62(4):527-531. doi: 10.2169/internalmedicine.0037-22. Epub 2022 Jul 14.

Traumatic MicroRNAs: Deconvolving the Signal After Severe Traumatic Brain Injury

Cente M, Matyasova K, Csicsatkova N, Tomikova A, Porubska S, Niu Y, Majdan M, Filipcik P, Jurisica I.

Cell Mol Neurobiol. 2023 Apr;43(3):1061-1075. doi: 10.1007/s10571-022-01254-z. Epub 2022 Jul 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias